AZN · NYSE
AstraZeneca (AZN) Stock Price & Fundamentals
$366.04+1.69%+$6.09End-of-day price as of Oct 9, 2026
Sample prices
Prices on this page are generated sample data for development, not real market data, so market cap, P/E and dividend yield are illustrative too.
AstraZeneca (AZN) closed at $366.04 on Oct 9, 2026, up 1.69% from the previous close of $359.95.
Share price, past year
1Y −4.67%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $366.04 |
| Sep 30, 2026 | $361.59 |
| Aug 31, 2026 | $368.84 |
| Jul 31, 2026 | $369.58 |
| Jun 30, 2026 | $366.66 |
| May 29, 2026 | $363.79 |
| Apr 30, 2026 | $368.72 |
| Mar 31, 2026 | $378.36 |
| Feb 27, 2026 | $385.01 |
| Jan 30, 2026 | $420.22 |
| Dec 31, 2025 | $423.66 |
| Nov 28, 2025 | $402.97 |
| Oct 31, 2025 | $374.86 |
Key statistics
- 52-week range
- $346.81 – $429.23
Financials
AstraZeneca reports to the SEC in international accounting standards (IFRS), which Laurel doesn't show yet.
Company profile
- Name
- AstraZeneca PLC
- Ticker
- AZN
- Exchange
- NYSE
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA
- Incorporated in
- X0
- Fiscal year ends
- December
- SEC CIK
- 0000901832
Frequently asked questions
What is AstraZeneca's stock price?
AstraZeneca (AZN) closed at $366.04 on Oct 9, 2026, up 1.69% from the previous close of $359.95.
Sources and methodology
Fundamentals come from AstraZeneca PLC's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures